|
Thrombocyte function in relation to the long term application of medroxyprogesterone acetate as a female contraceptive agent
L Mettler, D Shirwani, FJ Brunnberg
Department of Obetetrics and Gynaecology, University of kiel
Correspondence Address:
L Mettler
Department of Obetetrics and Gynaecology, University of kiel
In two hundred and twenty eight parous women between thirty and forty years o f age, Medroxyprogesterone acetate 150 mg depot injection every three months proved to be a one hundred per cent contraceptive agent. Minimal side effects were noted with some spotting and amenorrhoea. No significant increase in blood coagulation and tendency to thrombosis was noted as tested by the platelet aggregation test during medication.
How to cite this article:
Mettler L, Shirwani D, Brunnberg F J. Thrombocyte function in relation to the long term application of medroxyprogesterone acetate as a female contraceptive agent.J Postgrad Med 1979;25:154-157
|
How to cite this URL:
Mettler L, Shirwani D, Brunnberg F J. Thrombocyte function in relation to the long term application of medroxyprogesterone acetate as a female contraceptive agent. J Postgrad Med [serial online] 1979 [cited 2023 Oct 1 ];25:154-157
Available from: https://www.jpgmonline.com/article.asp?issn=0022-3859;year=1979;volume=25;issue=3;spage=154;epage=157;aulast=Mettler;type=0 |
|
|
|
